Trials / Recruiting
RecruitingNCT06924359
Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Peking University First Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- —
Summary
With the accelerating global aging population, dementia has become a pressing worldwide issue. This project aims to identify specific plasma biomarkers and ocular indicators for the early detection of Alzheimer's disease (AD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Multimodal Ophthalmic Imaging and plasma biomarker | Multimodal Ophthalmic Imaging and plasma biomarkers (Aβ42/40, p-tau181, p-tau217, NfL and GFAP）. |
Timeline
- Start date
- 2025-03-19
- Primary completion
- 2027-08-31
- Completion
- 2027-08-31
- First posted
- 2025-04-11
- Last updated
- 2025-04-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06924359. Inclusion in this directory is not an endorsement.